AzTrials
AzTrials

Undescended TestisNCT02731989

Comparison Between the Clinical Assessment of the Undescended Testis and Its' Ultrasonographic Size

An observational study of Undescended Testis, run by Meir Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In addition to the manual preoperative examination, the undescended testicle will be measured ultrasonographically. The compared data will help us to evaluate the routine need for preoperative ultrasonographic evaluation of the undescended testicle. Read more about this study

Who is it for?
Ages 1 year to 13 years, men only
Conditions the study is for
Undescended Testis
How many people
60 participants
Where
1 siteIsrael
Study dates
24 Jul 2017to 24 Jul 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 13 years
  • Men only
  • No healthy volunteers
  • Child

Study population: Boys operated for unilateral cryptorchism

Who may be able to join

  • Boys operated for unilateral cryptorchism

Who cannot join

  • bilateral cryptorchism recurrent operation s/p inguinal operation

Trial locations and contacts

1 site in 1 country.

Israel1 site, 1 recruiting
  • Meir Medical Centre

    Kfar Saba, 44281

    Zvi Steiner, MD, 050-6246788, zvi.steiner@clalit.org.il

    Recruiting

Other trials in Israel

About this study

In addition to the manual preoperative examination, the undescended testicle will be measured ultrasonographically. The compared data will help us to evaluate the routine need for preoperative ultrasonographic evaluation of the undescended testicle.

Medical subject headings
Cryptorchidism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02731989
Study groupRoleWhat they receive
study groupThe surgeon will estimate the size difference between the undescended and the normally located testis. Independently the ultrasonographer will measure the true size of both testes in the study group.
Control groupThe same measurments will be done by the surgeon and the ultrasonographer on boys without cryptorchism.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The difference between the testicular size estimated by the surgeon and the actual ultrasonographic size

    The difference between the testicular size estimated by the surgeon and the actual ultrasonographic size

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2016 (estimated)
  2. Study start24 Jul 2017 (estimated)
  3. Primary completion24 Jul 2018 (estimated)
  4. Study completion24 Jul 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02731989
Sponsor's protocol ID
0090-16-MMC
Status last verified
Jul 2017
First submitted
4 Apr 2016
Last updated
13 Jul 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Undescended Testis, run by Meir Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Zvi Steiner, MD (050-6246788, zvi.steiner@clalit.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The difference between the testicular size estimated by the surgeon and the actual ultrasonographic size (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in